Virios Therapeutics (VIRI) Tops Q2 EPS by 7c
Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.44), $0.07 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.44), $0.07 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.